文献速递临床试验与 GCP真实世界研究与卫生经济

ADAPT试验:以姑息治疗推进症状缓解以改善生活质量的随机临床试验方案

Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2019-06-13

ADAPT试验为两站点、患者层面随机临床试验,纳入生活质量差且住院或死亡风险升高的慢性心力衰竭、慢性阻塞性肺疾病或间质性肺病退伍军人,比较多学科团队干预与常规照护对6个月患者报告生活质量的影响,主要结局为功能评估慢性病治疗-一般问卷评分变化。

要点

  • ADAPT干预由注册护士、社会工作者、姑息治疗专家和初级保健提供者组成的多学科团队每周会议提出建议。
  • 主要结局为6个月时功能评估慢性病治疗-一般问卷所测患者报告生活质量的变化。
  • 次要结局包括症状困扰、抑郁、焦虑、疾病特异性生活质量、住院及预立照护规划沟通与记录的变化。

核心结论

  • ADAPT试验旨在确定多学科团队干预对慢性心力衰竭、慢性阻塞性肺疾病或间质性肺病患者生活质量的影响。

研究设计与样本

  • ADAPT试验为两站点、患者层面随机临床试验,比较ADAPT干预与常规照护对6个月患者报告生活质量的有效性。
  • 研究对象为生活质量差且住院或死亡风险升高的慢性心力衰竭、慢性阻塞性肺疾病或间质性肺病退伍军人。

主要发现

  • ADAPT干预包括由注册护士、社会工作者、姑息治疗专家和初级保健提供者组成的多学科团队,可咨询肺科医生和心脏科医生,每周会议提出建议并开具医嘱供参与者各自的初级保健提供者考虑。
  • 护士和社会工作者与参与者进行六次互动,以识别和管理一个主要困扰症状,并完成结构化心理社会干预和预立照护规划。
  • 主要结局为6个月时功能评估慢性病治疗-一般问卷所测患者报告生活质量的变化。
  • 6个月次要结局包括症状困扰、抑郁、焦虑、疾病特异性生活质量、住院及预立照护规划沟通与记录的变化。
  • 干预实施评估采用混合方法,包括对参与者和干预人员体验的定性评估以及对照护提供、资源和成本的定量评估。

临床怎么用

  • ADAPT试验研究一种创新干预,针对损害生活质量但疾病特异性治疗下仍持续存在的关键因素——症状和抑郁,以改善患有常见沉重疾病退伍军人的生活价值。
  • 利用 affiliate health providers 在医生监督下的技能将扩展姑息治疗的可及性,并在常规门诊照护中改善晚期疾病患者的生活质量。
  • ADAPT试验的混合效果/实施设计若干预有效将缩短广泛传播的时间并创造未来研究的途径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People living with chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD) suffer impaired quality of life due to burdensome symptoms and depression. The Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial aims to determine the effect of a multidisciplinary, team-based intervention on quality of life in people with these common diseases. METHODS/DESIGN: The ADAPT trial is a two-site, patient-level randomized clinical trial that examines the effectiveness of the ADAPT intervention compared to usual care on patient-reported quality of life at 6 months in veterans with CHF, COPD or ILD with poor quality of life and increased risk for hospitalization or death. The ADAPT intervention involves a multidisciplinary team-a registered nurse, social worker, palliative care specialist, and primary care provider (with access to a pulmonologist and cardiologist)-who meet weekly to make recommendations and write orders for consideration by participants' individual primary care providers. The nurse and social worker interact with participants over six visits to identify and manage a primary bothersome symptom and complete a structured psychosocial intervention and advance care planning. The primary outcome is change in patient-reported quality of life at 6 months as measured by the Functional Assessment of Chronic Illness Therapy-General questionnaire. Secondary outcomes at 6 months include change in symptom distress, depression, anxiety, disease-specific quality of life hospitalizations, and advance care planning communication and documentation. Intervention implementation will be assessed using a mixed-methods approach including a qualitative assessment of participants' and intervention personnel experiences and a quantitative assessment of care delivery, resources, and cost. DISCUSSION: The ADAPT trial studies an innovative intervention designed to improve quality of life for veterans with common, burdensome illnesses by targeting key underlying factors-symptoms and depression-that impair quality of life but persist despite disease-specific therapies. Leveraging the skills of affiliate health providers with physician supervision will extend the reach of palliative care and improve quality of life for those with advanced disease within routine outpatient care. The hybrid effectiveness/implementation design of the ADAPT trial will shorten the time to broader dissemination if effective and create avenues for future research. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02713347 . Registered March 19, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Graney BA, Au DH, Barón AE, et al. Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial. Trials. 2019. PMID: 31196156. doi:10.1186/s13063-019-3417-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。